| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_781234f3bbb66c6fda75dc8db9f2a283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a80efa42d5ff140961a2acc035641db8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d74e8ae879f3711bcfb4c399a7b21681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32df02107f226eddd26140c32697fe17 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f904fac8ccbaa38918e800e06259fbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c883483de4830fec0e5777dbc7b2bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e213659d8955deb9a2d099d8558fc6 |
| publicationDate |
2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9844515-B2 |
| titleOfInvention |
Transdermal therapeutic system comprising buprenorphine |
| abstract |
The invention is concerned with a transdermal therapeutic system (TTS) comprising buprenorphine and a method of manufacturing such a TTS. The transdermal therapeutic system is used for the transdermal administration of buprenorphine and analogues thereof. In particular, the invention relates to the use of a transdermal therapeutic system (TTS) for analgesic purposes. The TTS according to the invention comprises a transdermal drug delivery composition comprising buprenorphine and an adhesive component, which is a mixture of a crosslinked and a non-crosslinked acrylic polymer and a penetration enhancer comprising a keto acid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337932-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017340578-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033512-B2 |
| priorityDate |
2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |